Finance

Lists
4516:TYO
Nippon Shinyaku Co Ltd
JP¥ ३,३७७.००
०.००%
(०.००) 1D
नोभेम्बर १८, १५:३०:०० GMT+९  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4516...
Mkt. cap
२.३७ खरब
Avg. vol.
३.६४ लाख
Volume
०.००
Dividend
३.६७%
Quarterly dividend
JP¥ ३१
Ex-dividend date
२०२६ सेप्टेम्बर २९
P/E ratio
७.७३
52-wk high
JP¥ ६,५२९
52-wk low
JP¥ ३,३०२
EPS
JP¥ ४३७
Shares outstanding
६.७४ करोड
No. of employees
२ हजार
Mkt. cap
२.३७ खरब
Avg. vol.
३.६४ लाख
Volume
०.००
Dividend
३.६७%
Quarterly dividend
JP¥ ३१
Ex-dividend date
२०२६ सेप्टेम्बर २९
P/E ratio
७.७३
52-wk high
JP¥ ६,५२९
52-wk low
JP¥ ३,३०२
EPS
JP¥ ४३७
Shares outstanding
६.७४ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
RealMoney Pro
RealMoney Pro
·
१ घण्टा पहिले
A Concerning Nvidia Reversal Pulls the S&P 500 to a Fifth Down Day
FXStreet
FXStreet
·
१ घण्टा पहिले
Dow Jones Industrial Average drops as UnitedHealth and Nvidia fall
Traders Union
Traders Union
·
२ घण्टा पहिले
Peter Tuchman: S&P 500 loses $2.5 trillion in market cap over five days
Profile
Nippon Shinyaku Co., Ltd. is a Japanese pharmaceutical company headquartered in Kyoto that markets prescription drugs and functional foods. Nippon Shinyaku has developed treatments such as viltolarsen for Duchenne muscular dystrophy. Wikipedia
About Nippon Shinyaku Co Ltd
CEO-
Employees२.३१ हजार
Founded१९१९ अक्टोबर १
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
४७.४९ अरब
४३.६४ अरब
४९.०७ अरब
४८.७६ अरब
Cost of goods sold
१६.६८ अरब
१५.४५ अरब
१७.७३ अरब
१६.७८ अरब
Cost of revenue
१६.६८ अरब
१५.४५ अरब
१७.७३ अरब
१६.७८ अरब
Research and development expenses
८.४० अरब
१३.६८ अरब
९.२० अरब
११.४८ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
११.३५ अरब
१०.८९ अरब
११.०८ अरब
११.६९ अरब
Operating expense
१८.०६ अरब
२७.५५ अरब
१९.०३ अरब
२५.०२ अरब
Total operating expenses
३४.७३ अरब
४३.०० अरब
३६.७५ अरब
४१.८० अरब
Operating income
१२.७५ अरब
६३.९० करोड
१२.३१ अरब
६.९६ अरब
Other non operating income
-२०.०० लाख
३२.३० करोड
-१०.०० लाख
-२०.०० लाख
EBT including unusual items
१३.२० अरब
३.२४ अरब
१२.९६ अरब
७.०४ अरब
EBT excluding unusual items
१३.२० अरब
३.३५ अरब
१२.९६ अरब
७.०४ अरब
Income tax expense
३.११ अरब
-६४.२० करोड
२.८५ अरब
१.६८ अरब
Effective tax rate
२३.५७%
-१९.८३%
२२.००%
२३.८५%
Other operating expenses
-१.६८ अरब
२.०१ अरब
-१.२४ अरब
१.८५ अरब
Net income
१०.०८ अरब
३.८८ अरब
१०.११ अरब
५.३६ अरब
Net profit margin
२१.२३%
८.८८%
२०.६०%
११.००%
Earnings per share
-
-
-
-
Interest and investment income
४६.४० करोड
११.९० करोड
६८.९० करोड
१४.८० करोड
Interest expense
-१.९० करोड
-
-४.१० करोड
-६.२० करोड
Net interest expenses
४४.५० करोड
११.९० करोड
६४.८० करोड
८.६० करोड
Depreciation and amortization charges
-
९७.४० करोड
-
-
EBITDA
१४.४१ अरब
२.३८ अरब
१४.०९ अरब
८.८१ अरब
Gain or loss from assets sale
५.६० करोड
५.६० करोड
-४७.३० करोड
१८.१० करोड
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू